ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$126.05

Market cap

$222.89B

P/E Ratio

31.05

Dividend/share

$1.82

EPS

$4.06

Enterprise value

$231.99B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
Abbott Laboratories's net income has surged by 114% YoY and by 14% QoQ
The EPS has soared by 114% YoY and by 14% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.abbott.com
Peers: JNJ PFE MDT TMO

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.77B
Market cap
$222.89B
Enterprise value
$231.99B
Valuations
Price to earnings (P/E)
31.05
Price to book (P/B)
6.45
Price to sales (P/S)
5.29
EV/EBIT
26.32
EV/EBITDA
18.81
EV/Sales
5.48
Earnings
Revenue
$42.31B
EBIT
$8.81B
EBITDA
$12.34B
Free cash flow
$9.31B
Per share
EPS
$4.06
Free cash flow per share
$5.25
Book value per share
$19.54
Revenue per share
$23.84
TBVPS
$20.95
Balance sheet
Total assets
$73.8B
Total liabilities
$39.16B
Debt
$18.4B
Equity
$34.64B
Working capital
$10.63B
Liquidity
Debt to equity
0.53
Current ratio
1.83
Quick ratio
1.25
Net debt/EBITDA
0.74
Margins
EBITDA margin
29.2%
Gross margin
56.8%
Net margin
17.1%
Operating margin
20%
Efficiency
Return on assets
9.9%
Return on equity
21.4%
Return on invested capital
26.3%
Return on capital employed
14.5%
Return on sales
20.8%
Dividend
Dividend yield
1.44%
DPS
$1.82
Payout ratio
44.8%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
-0.41%
1 week
-5.74%
1 month
-8.07%
1 year
11.97%
YTD
-10.44%
QTD
-10.44%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$42.31B
Gross profit
$24.04B
Operating income
$8.48B
Net income
$7.24B
Gross margin
56.8%
Net margin
17.1%
Abbott Laboratories's net income has surged by 114% YoY and by 14% QoQ
The operating income has soared by 97% YoY and by 14% from the previous quarter
Abbott Laboratories's net margin has surged by 63% YoY and by 8% QoQ
Abbott Laboratories's operating margin has increased by 49% YoY and by 8% from the previous quarter

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
31.05
P/B
6.45
P/S
5.29
EV/EBIT
26.32
EV/EBITDA
18.81
EV/Sales
5.48
The EPS has soared by 114% YoY and by 14% from the previous quarter
ABT's P/E is 58% below its 5-year quarterly average of 73.7 and 13% below its last 4 quarters average of 35.6
ABT's price to book (P/B) is 43% higher than its 5-year quarterly average of 4.5 and 6% higher than its last 4 quarters average of 6.1
ABT's equity is up by 10% year-on-year
The revenue has grown by 31% YoY and by 5% from the previous quarter
ABT's P/S is 18% above its 5-year quarterly average of 4.5

Efficiency

How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has surged by 98% YoY and by 11% QoQ
ABT's ROE has soared by 96% YoY and by 11% from the previous quarter
The ROIC has soared by 95% YoY and by 14% from the previous quarter
The ROS has soared by 52% YoY and by 8% from the previous quarter

Dividends

What is ABT's dividend history
Dividend details
DPS
$1.82
Dividend yield
1.44%
Payout ratio
44.8%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 88% more than the total liabilities
ABT's quick ratio is up by 24% year-on-year and by 5% since the previous quarter
The current ratio has increased by 8% YoY and by 2.2% QoQ
Abbott Laboratories's debt is 47% lower than its equity
Abbott Laboratories's debt to equity has decreased by 10% YoY
ABT's equity is up by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.